British Columbia Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.66M | Sell |
|
|||||
|
2025
Q1 | $2.58M | Sell |
|
|||||
|
2024
Q4 | $2.4M | Buy |
|
|||||
|
2024
Q3 | $2.23M | Sell |
|
|||||
|
2024
Q2 | $2.99M | Buy |
|
|||||
|
2024
Q1 | $1.96M | Buy |
|
|||||
|
2023
Q4 | $2.09M | Buy |
|
|||||
|
2023
Q3 | $1.51M | Buy |
|
|||||
|
2023
Q2 | $1.47M | Buy |
|
|||||
|
2023
Q1 | $1.6M | Hold |
|
|||||
|
2022
Q4 | $1.7M | Sell |
|
|||||
|
2022
Q3 | $1.55M | Sell |
|
|||||
|
2022
Q2 | $1.76M | Sell |
|
|||||
|
2022
Q1 | $2.19M | Sell |
|
|||||
|
2021
Q4 | $2.84M | Sell |
|
|||||
|
2021
Q3 | $2.61M | Buy |
|
|||||
|
2021
Q2 | $2.8M | Buy |
|
|||||
|
2021
Q1 | $2.25M | Sell |
|
|||||
|
2020
Q4 | $2.68M | Sell |
|
|||||
|
2020
Q3 | $2.39M | Buy |
|
|||||
|
2020
Q2 | $3.55M | Buy |
|
|||||
|
2020
Q1 | $1.66M | Sell |
|
|||||
|
2019
Q4 | $3.58M | Buy |
|
|||||
|
2019
Q3 | $2.76M | Sell |
|
|||||
|
2019
Q2 | $4.37M | Buy |
|
|||||
|
2019
Q1 | $4.32M | Sell |
|
|||||
|
2018
Q4 | $5.13M | Buy |
|
|||||
|
2018
Q3 | $5.27M | Sell |
|
|||||
|
2018
Q2 | $6.98M | Sell |
|
|||||
|
2018
Q1 | $7.63M | Sell |
|
|||||
|
2017
Q4 | $10.5M | Buy |
|
|||||
|
2017
Q3 | $10.2M | Buy |
|
|||||
|
2017
Q2 | $9.65M | Buy |
|
|||||
|
2017
Q1 | $8.62M | Sell |
|
|||||
|
2016
Q4 | $8.43M | Buy |
|
|||||
|
2016
Q3 | $8.16M | Sell |
|
|||||
|
2016
Q2 | $7.85M | Hold |
|
|||||
|
2016
Q1 | $8.32M | Buy |
|
|||||
|
2015
Q4 | $10.1M | Buy |
|
|||||
|
2015
Q3 | $4.48M | Buy |
|
|||||
|
2015
Q2 | $4.23M | Sell |
|
|||||
|
2015
Q1 | $4.29M | Sell |
|
|||||
|
2014
Q4 | $4.89M | Buy |
|
|||||
|
2014
Q3 | $1.13M | Hold |
|
|||||
|
2014
Q2 | $971K | Buy |
|
|||||
|
2014
Q1 | $575K | Sell |
|
|||||
|
2013
Q4 | $1.7M | Sell |
|
|||||
|
2013
Q3 | $5.79M | Buy |
|
|||||
|
2013
Q2 | $616K | Buy |
|